{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:33:08Z","timestamp":1787729588323,"version":"build-2784847793"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11030-024-11096-0","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:54:10Z","timestamp":1737341650000},"page":"3253-3272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["General structure-activity relationship models for the inhibitors of Adenosine receptors: A machine learning approach"],"prefix":"10.1007","volume":"29","author":[{"given":"M.","family":"Janbozorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaveh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Neiband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mani-Varnosfaderani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"1","key":"11096_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB et al (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63(1):1\u201334","journal-title":"Pharmacol Rev"},{"key":"11096_CR2","doi-asserted-by":"publisher","first-page":"113907","DOI":"10.1016\/j.ejmech.2021.113907","volume":"227","author":"A Saini","year":"2022","unstructured":"Saini A et al (2022) Adenosine receptor antagonists: Recent advances and therapeutic perspective. Eur J Med Chem 227:113907","journal-title":"Eur J Med Chem"},{"key":"11096_CR3","doi-asserted-by":"publisher","first-page":"320873","DOI":"10.3389\/fphar.2017.00985","volume":"8","author":"I Ballesteros-Y\u00e1\u00f1ez","year":"2018","unstructured":"Ballesteros-Y\u00e1\u00f1ez I et al (2018) The role of adenosine receptors in psychostimulant addiction. Front Pharmacol 8:320873","journal-title":"Front Pharmacol"},{"key":"11096_CR4","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1080\/07391102.2018.1517612","volume":"37","author":"Y Yang","year":"2019","unstructured":"Yang Y et al (2019) Exploring the structural determinants of novel xanthine derivatives as A2B adenosine receptor antagonists: a computational study. J Biomol Struct Dynamics 37:3467","journal-title":"J Biomol Struct Dynamics"},{"issue":"5","key":"11096_CR5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1021\/acs.jmedchem.5b01586","volume":"59","author":"A El Maatougui","year":"2016","unstructured":"El Maatougui A et al (2016) Discovery of potent and highly selective A2B adenosine receptor antagonist chemotypes. J Med Chem 59(5):1967\u20131983","journal-title":"J Med Chem"},{"issue":"3","key":"11096_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao Z-G (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discovery 5(3):247\u2013264","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"11096_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/cr0682195","volume":"108","author":"PG Baraldi","year":"2008","unstructured":"Baraldi PG et al (2008) Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 108(1):238\u2013263","journal-title":"Chem Rev"},{"issue":"5","key":"11096_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.bbamem.2010.12.017","volume":"1808","author":"CE M\u00fcller","year":"2011","unstructured":"M\u00fcller CE, Jacobson KA (2011) Recent developments in adenosine receptor ligands and their potential as novel drugs. Biochimica Et Biophysica Acta (BBA)-Biomembranes 1808(5):1290\u20131308","journal-title":"Biochimica Et Biophysica Acta (BBA)-Biomembranes"},{"issue":"4","key":"11096_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB et al (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527\u2013552","journal-title":"Pharmacol Rev"},{"issue":"4","key":"11096_CR10","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.bmc.2007.11.026","volume":"16","author":"MP Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez MP et al (2008) New QSAR combined strategy for the design of A1 adenosine receptor agonists. Bioorg Med Chem 16(4):1658\u20131675","journal-title":"Bioorg Med Chem"},{"key":"11096_CR11","doi-asserted-by":"publisher","first-page":"111936","DOI":"10.1016\/j.ejmech.2019.111936","volume":"187","author":"Y Wei","year":"2020","unstructured":"Wei Y et al (2020) Identification of new potent A1 adenosine receptor antagonists using a multistage virtual screening approach. Eur J Med Chem 187:111936","journal-title":"Eur J Med Chem"},{"key":"11096_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"F Bb","year":"2001","unstructured":"Bb F (2001) International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"issue":"1","key":"11096_CR13","doi-asserted-by":"publisher","first-page":"e0204378","DOI":"10.1371\/journal.pone.0204378","volume":"14","author":"F Fan","year":"2019","unstructured":"Fan F et al (2019) The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: a case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs. PLoS ONE 14(1):e0204378","journal-title":"PLoS ONE"},{"issue":"16","key":"11096_CR14","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1042\/BCJ20190251","volume":"476","author":"SA Choudhary","year":"2019","unstructured":"Choudhary SA et al (2019) A novel small molecule A2A adenosine receptor agonist, indirubin-3\u2032-monoxime, alleviates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes. Biochem J 476(16):2371\u20132391","journal-title":"Biochem J"},{"key":"11096_CR15","doi-asserted-by":"publisher","first-page":"130080","DOI":"10.1016\/j.molstruc.2021.130080","volume":"1232","author":"NR Das","year":"2021","unstructured":"Das NR, Mishra SP, Achary PGR (2021) Evaluation of molecular structure based descriptors for the prediction of pEC50 (M) for the selective adenosine A2A Receptor. J Mol Struct 1232:130080","journal-title":"J Mol Struct"},{"issue":"9","key":"11096_CR16","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.drudis.2019.05.011","volume":"24","author":"PK Deb","year":"2019","unstructured":"Deb PK et al (2019) Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives. Drug Discovery Today 24(9):1854\u20131864","journal-title":"Drug Discovery Today"},{"key":"11096_CR17","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1007\/s00044-012-0453-8","volume":"22","author":"M Mansourian","year":"2013","unstructured":"Mansourian M et al (2013) Linear and nonlinear QSAR modeling of 1, 3, 8-substituted-9-deazaxanthines as potential selective A 2B AR antagonists. Med Chem Res 22:4549\u20134567","journal-title":"Med Chem Res"},{"issue":"2","key":"11096_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/tvst.11.2.30","volume":"11","author":"Y Kim","year":"2022","unstructured":"Kim Y et al (2022) HL3501, a novel selective A3 adenosine receptor antagonist, lowers intraocular pressure (IOP) in animal glaucoma models. Translational Vision Sci Technol 11(2):30\u201330","journal-title":"Translational Vision Sci Technol"},{"key":"11096_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jmgm.2013.03.001","volume":"42","author":"AM Almerico","year":"2013","unstructured":"Almerico AM et al (2013) A3 adenosine receptor: homology modeling and 3D-QSAR studies. J Mol Graph Model 42:60\u201372","journal-title":"J Mol Graph Model"},{"issue":"2","key":"11096_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/med.20254","volume":"33","author":"SL Cheong","year":"2013","unstructured":"Cheong SL et al (2013) The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches. Med Res Rev 33(2):235\u2013335","journal-title":"Med Res Rev"},{"issue":"22","key":"11096_CR21","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1016\/j.bmc.2011.09.032","volume":"19","author":"F Luan","year":"2011","unstructured":"Luan F et al (2011) Affinity prediction on A3 adenosine receptor antagonists: the chemometric approach. Bioorg Med Chem 19(22):6853\u20136859","journal-title":"Bioorg Med Chem"},{"issue":"06","key":"11096_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1142\/S0219633610006146","volume":"9","author":"SS Ahmed","year":"2010","unstructured":"Ahmed SS, Ahameethunisa A, Santosh W (2010) QSAR and pharmacophore modeling of 4-arylthieno [3, 2-d] pyrimidine derivatives against adenosine receptor of Parkinson\u2019s disease. J Theor Comput Chem 9(06):975\u2013991","journal-title":"J Theor Comput Chem"},{"key":"11096_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-020-00438-3","volume":"12","author":"L Burggraaff","year":"2020","unstructured":"Burggraaff L et al (2020) Quantitative prediction of selectivity between the A 1 and A 2A adenosine receptors. J Cheminformatics 12:1\u201316","journal-title":"J Cheminformatics"},{"issue":"12","key":"11096_CR24","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1021\/ci900311j","volume":"49","author":"L Michielan","year":"2009","unstructured":"Michielan L et al (2009) Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study. J Chem Inf Model 49(12):2820\u20132836","journal-title":"J Chem Inf Model"},{"issue":"2","key":"11096_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/biomedicines10020491","volume":"10","author":"VV Kleandrova","year":"2022","unstructured":"Kleandrova VV, Speck-Planche A (2022) PTML modeling for pancreatic cancer research: in silico design of simultaneous multi-protein and multi-cell inhibitors. Biomedicines 10(2):491","journal-title":"Biomedicines"},{"key":"11096_CR26","doi-asserted-by":"publisher","first-page":"634663","DOI":"10.3389\/fchem.2021.634663","volume":"9","author":"VV Kleandrova","year":"2021","unstructured":"Kleandrova VV et al (2021) QSAR modeling for multi-target drug discovery: designing simultaneous inhibitors of proteins in diverse pathogenic parasites. Front Chem 9:634663","journal-title":"Front Chem"},{"issue":"D1","key":"11096_CR27","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson MK et al (2016) BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44(D1):D1045\u2013D1053","journal-title":"Nucleic Acids Res"},{"key":"11096_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s11030-019-10013-0","volume":"24","author":"M Neiband","year":"2020","unstructured":"Neiband M, Benvidi A, Mani-Varnosfaderani A (2020) Development of classification models for identification of important structural features of isoform-selective histone deacetylase inhibitors (class I). Mol Divers 24:1077\u20131094","journal-title":"Mol Divers"},{"issue":"7\u20138","key":"11096_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/1062936X.2011.623318","volume":"22","author":"M Jalali-Heravi","year":"2011","unstructured":"Jalali-Heravi M et al (2011) Classification of anti-HIV compounds using counterpropagation artificial neural networks and decision trees. SAR QSAR Environ Res 22(7\u20138):639\u2013660","journal-title":"SAR QSAR Environ Res"},{"issue":"3","key":"11096_CR30","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1021\/acs.jmedchem.8b01662","volume":"62","author":"DK Tosh","year":"2019","unstructured":"Tosh DK et al (2019) Design and in vivo characterization of A1 adenosine receptor agonists in the native ribose and conformationally constrained (N)-Methanocarba series. J Med Chem 62(3):1502\u20131522","journal-title":"J Med Chem"},{"issue":"6","key":"11096_CR31","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.bmc.2017.02.029","volume":"25","author":"S Koul","year":"2017","unstructured":"Koul S et al (2017) Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation. Bioorg Med Chem 25(6):1963\u20131975","journal-title":"Bioorg Med Chem"},{"issue":"23","key":"11096_CR32","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1021\/acs.jmedchem.6b01068","volume":"59","author":"F Varano","year":"2016","unstructured":"Varano F et al (2016) Design, synthesis, and pharmacological characterization of 2-(2-furanyl) thiazolo [5, 4-d] pyrimidine-5, 7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity. J Med Chem 59(23):10564\u201310576","journal-title":"J Med Chem"},{"issue":"5","key":"11096_CR33","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1021\/acs.jmedchem.5b00074","volume":"58","author":"R Petrelli","year":"2015","unstructured":"Petrelli R et al (2015) 5\u2032-C-ethyl-tetrazolyl-N 6-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. J Med Chem 58(5):2560\u20132566","journal-title":"J Med Chem"},{"key":"11096_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ejmech.2014.07.060","volume":"84","author":"L Squarcialupi","year":"2014","unstructured":"Squarcialupi L et al (2014) 7-Amino-2-phenylpyrazolo [4, 3-d] pyrimidine derivatives: structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies. Eur J Medicinal Chem 84:614\u2013627","journal-title":"Eur J Medicinal Chem"},{"key":"11096_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle NM et al (2011) Open babel: an open chemical toolbox. J cheminformatics 3:1\u201314","journal-title":"J cheminformatics"},{"issue":"1","key":"11096_CR36","doi-asserted-by":"publisher","first-page":"15315","DOI":"10.1038\/s41598-024-66173-z","volume":"14","author":"S Kaveh","year":"2024","unstructured":"Kaveh S, Mani-Varnosfaderani A, Neiband MS (2024) Deriving general structure\u2013activity\/selectivity relationship patterns for different subfamilies of cyclin-dependent kinase inhibitors using machine learning methods. Sci Rep 14(1):15315","journal-title":"Sci Rep"},{"issue":"1","key":"11096_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/152791602317250351","volume":"3","author":"D Laxmi","year":"2002","unstructured":"Laxmi D, Priyadarshy S (2002) HyperChem 6 03. Biotech Softw Internet Rep: Comput Softw J Sci 3(1):5\u20139","journal-title":"Biotech Softw Internet Rep: Comput Softw J Sci"},{"issue":"2","key":"11096_CR38","first-page":"237","volume":"56","author":"A Mauri","year":"2006","unstructured":"Mauri A et al (2006) Dragon software: an easy approach to molecular descriptor calculations. Match 56(2):237\u2013248","journal-title":"Match"},{"key":"11096_CR39","first-page":"1","volume":"42","author":"M Darsaraee","year":"2023","unstructured":"Darsaraee M et al (2023) General structure-activity\/selectivity relationship patterns for the inhibitors of the chemokine receptors (CCR1\/CCR2\/CCR4\/CCR5) with application for virtual screening of pubchem database. J Biomol Struct Dynamics 42:1\u201319","journal-title":"J Biomol Struct Dynamics"},{"key":"11096_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.chemolab.2014.03.020","volume":"135","author":"B Lu","year":"2014","unstructured":"Lu B et al (2014) Industrial PLS model variable selection using moving window variable importance in projection. Chemom Intell Lab Syst 135:90\u2013109","journal-title":"Chemom Intell Lab Syst"},{"issue":"10","key":"11096_CR41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cem.2736","volume":"29","author":"M Farr\u00e9s","year":"2015","unstructured":"Farr\u00e9s M et al (2015) Comparison of the variable importance in projection (VIP) and of the selectivity ratio (SR) methods for variable selection and interpretation. J Chemom 29(10):528\u2013536","journal-title":"J Chemom"},{"key":"11096_CR42","doi-asserted-by":"publisher","first-page":"100378","DOI":"10.1016\/j.cosrev.2021.100378","volume":"40","author":"F Anowar","year":"2021","unstructured":"Anowar F, Sadaoui S, Selim B (2021) Conceptual and empirical comparison of dimensionality reduction algorithms (pca, kpca, lda, mds, svd, lle, isomap, le, ica, t-sne). Comput Sci Rev 40:100378","journal-title":"Comput Sci Rev"},{"issue":"5","key":"11096_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cageo.2004.10.009","volume":"31","author":"BS Penn","year":"2005","unstructured":"Penn BS (2005) Using self-organizing maps to visualize high-dimensional data. Comput Geosci 31(5):531\u2013544","journal-title":"Comput Geosci"},{"issue":"1","key":"11096_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-7439(97)00030-0","volume":"38","author":"J Zupan","year":"1997","unstructured":"Zupan J, Novi\u010d M, Ruis\u00e1nchez I (1997) Kohonen and counterpropagation artificial neural networks in analytical chemistry. Chemom Intell Lab Syst 38(1):1\u201323","journal-title":"Chemom Intell Lab Syst"},{"key":"11096_CR45","doi-asserted-by":"crossref","unstructured":"Cartwright, H.M., Artificial neural networks in biology and chemistry\u2014the evolution of a new analytical tool. Artificial Neural Networks: Methods and Applications, 2009: p. 1\u201313.","DOI":"10.1007\/978-1-60327-101-1_1"},{"issue":"15","key":"11096_CR46","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.3390\/ijms21155542","volume":"21","author":"A Rakhimbekova","year":"2020","unstructured":"Rakhimbekova A et al (2020) Comprehensive analysis of applicability domains of QSPR models for chemical reactions. Int J Mol Sci 21(15):5542","journal-title":"Int J Mol Sci"},{"issue":"5","key":"11096_CR47","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.3390\/molecules17054791","volume":"17","author":"F Sahigara","year":"2012","unstructured":"Sahigara F et al (2012) Comparison of different approaches to define the applicability domain of QSAR models. Molecules 17(5):4791\u20134810","journal-title":"Molecules"},{"key":"11096_CR48","unstructured":"lnc, T.M., MATLAB version 2018b. 2018."},{"key":"11096_CR49","unstructured":"Team, R.C., R:A Language and Enviroonment for Statistical Computing. 2021."},{"key":"11096_CR50","volume-title":"Molecular descriptors for chemoinformatics : volume I: alphabetical listing\/volume II: appendices, references","author":"R Todeschini","year":"2009","unstructured":"Todeschini R, Consonni V (2009) Molecular descriptors for chemoinformatics : volume I: alphabetical listing\/volume II: appendices, references. Wiley, Hoboken"},{"issue":"11","key":"11096_CR51","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/molecules22111945","volume":"22","author":"W Jespers","year":"2017","unstructured":"Jespers W et al (2017) Structure-based design of potent and selective ligands at the four adenosine receptors. Molecules 22(11):1945","journal-title":"Molecules"},{"issue":"2","key":"11096_CR52","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bmcl.2010.11.094","volume":"21","author":"DP Kishore","year":"2011","unstructured":"Kishore DP et al (2011) QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives with human adenosine A3 receptor subtype. Bioorg Med Chem Lett 21(2):818\u2013823","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"11096_CR53","doi-asserted-by":"publisher","first-page":"e1007818","DOI":"10.1371\/journal.pcbi.1007818","volume":"16","author":"A Bruzzese","year":"2020","unstructured":"Bruzzese A, Dalton JA, Giraldo J (2020) Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions. PLoS Comput Biol 16(4):e1007818","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"11096_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1021\/jm100843z","volume":"54","author":"V Yaziji","year":"2011","unstructured":"Yaziji V et al (2011) Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 54(2):457\u2013471","journal-title":"J Med Chem"},{"key":"11096_CR55","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fphar.2017.00898","volume":"8","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Lebon G (2017) Human adenosine A2A receptor: molecular mechanism of ligand binding and activation. Front Pharmacol 8:898","journal-title":"Front Pharmacol"},{"issue":"1","key":"11096_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ph17010104","volume":"17","author":"B Nammalwar","year":"2024","unstructured":"Nammalwar B, Bunce RA (2024) Recent advances in pyrimidine-based drugs. Pharmaceuticals 17(1):104","journal-title":"Pharmaceuticals"},{"key":"11096_CR57","doi-asserted-by":"publisher","first-page":"13196","DOI":"10.1021\/acs.accounts.4c00452","volume":"57","author":"JY Yoo","year":"2024","unstructured":"Yoo JY et al (2024) Revisiting pyrimidine-embedded molecular frameworks to probe the unexplored chemical space for protein-protein interactions. Accounts Chem Res 57:13196\u2013575","journal-title":"Accounts Chem Res"},{"key":"11096_CR58","volume-title":"Handbook of molecular descriptors","author":"R Todeschini","year":"2008","unstructured":"Todeschini R, Consonni V (2008) Handbook of molecular descriptors. Wiley, Hoboken"},{"issue":"12","key":"11096_CR59","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1080\/10643389.2014.955627","volume":"45","author":"L Mamy","year":"2015","unstructured":"Mamy L et al (2015) Prediction of the fate of organic compounds in the environment from their molecular properties: a review. Crit Rev Environ Sci Technol 45(12):1277\u20131377","journal-title":"Crit Rev Environ Sci Technol"},{"key":"11096_CR60","doi-asserted-by":"crossref","unstructured":"Arteca, G.A., Molecular shape descriptors. Reviews in computational chemistry, 1996: p. 191\u2013253.","DOI":"10.1002\/9780470125861.ch5"},{"key":"11096_CR61","doi-asserted-by":"publisher","first-page":"111738","DOI":"10.1016\/j.ecoenv.2020.111738","volume":"208","author":"A Gajewicz-Skretna","year":"2021","unstructured":"Gajewicz-Skretna A et al (2021) Aquatic toxicity (Pre) screening strategy for structurally diverse chemicals: global or local classification tree models? Ecotoxicol Environ Saf 208:111738","journal-title":"Ecotoxicol Environ Saf"},{"issue":"20","key":"11096_CR62","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1039\/D1SC01000J","volume":"12","author":"S Koutsoukos","year":"2021","unstructured":"Koutsoukos S et al (2021) A review on machine learning algorithms for the ionic liquid chemical space. Chem Sci 12(20):6820\u20136843","journal-title":"Chem Sci"},{"issue":"5","key":"11096_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1747-0285.2008.00714.x","volume":"72","author":"TB Joseph","year":"2008","unstructured":"Joseph TB et al (2008) Quantitative structure activity relationship and pharmacophore studies of adenosine receptor A2B inhibitors. Chem Biol Drug Des 72(5):395\u2013408","journal-title":"Chem Biol Drug Des"},{"issue":"5","key":"11096_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/molecules25051245","volume":"25","author":"KLd Santos","year":"2020","unstructured":"Santos KLd et al (2020) Identification of novel chemical entities for adenosine receptor type 2a using molecular modeling approaches. Molecules 25(5):1245","journal-title":"Molecules"},{"key":"11096_CR65","unstructured":"Molecular Descriptors Guide."},{"issue":"12","key":"11096_CR66","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1021\/ci900313u","volume":"49","author":"R K\u00fchne","year":"2009","unstructured":"K\u00fchne R, Ebert R-U, Sch\u00fc\u00fcrmann G (2009) Chemical domain of QSAR models from atom-centered fragments. J Chem Inf Model 49(12):2660\u20132669","journal-title":"J Chem Inf Model"},{"issue":"1\u20133","key":"11096_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.theochem.2004.01.050","volume":"678","author":"V Lather","year":"2004","unstructured":"Lather V, Madan A (2004) Models for the prediction of adenosine receptors binding activity of 4-amino [1, 2, 4] triazolo [4, 3-a] quinoxalines. J Mol Struct (Thoechem) 678(1\u20133):1\u20139","journal-title":"J Mol Struct (Thoechem)"},{"issue":"2","key":"11096_CR68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1021\/ci010307x","volume":"42","author":"S El-Taher","year":"2002","unstructured":"El-Taher S, El-Sawy K, Hilal R (2002) Electronic structure of some adenosine receptor antagonists. VQSAR investigation. J chem inf comput sci 42(2):386\u2013392","journal-title":"J chem inf comput sci"},{"key":"11096_CR69","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10822-015-9861-4","volume":"29","author":"M McGann","year":"2015","unstructured":"McGann M, Nicholls A, Enyedy I (2015) The statistics of virtual screening and lead optimization. J Comput Aided Mol Des 29:923\u2013936","journal-title":"J Comput Aided Mol Des"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11096-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11096-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:25:36Z","timestamp":1757136336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11096-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["11096"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11096-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}